Compound information
- Natural Products
- ZC1056066
- Molecular Formula
- C20H31N3O4
- Molecular Weight
- 377.231456472 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-[[(1S)-1-carbamoyl-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C20H31N3O4/c1-13(2)10-16(18(21)24)22-19(25)17(11-14(3)4)23-20(26)27-12-15-8-6-5-7-9-15/h5-9,13-14,16-17H,10-12H2,1-4H3,(H2,21,24)(H,22,25)(H,23,26)/t16-,17-/m0/s1
- InChI Key
- JCFAUIGZYQYJPD-IRXDYDNUSA-N
- SMILES
- CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000004764244
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 110.52 Å2 | LogP | 3.012 |
LogS | -3.885 | LogD | 3.814 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.049 | Pgp substrate | 0.555 |
HIA | 0.813 | F20 % | 0.992 |
F30 % | 0.45 | Caco-2 | -5.164 |
MDCK | -4.764 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.266 | PPB | 81.16 |
VD | 0.875 | Fu | 1.197 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.723 |
CYP2A6 substrate | 0.39 | CYP2B6 substrate | 0.542 |
CYP2C19 inhibitor | 0.378 | CYP2C19 substrate | 0.967 |
CYP2C8 substrate | 0.799 | CYP2C9 inhibitor | 0.189 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.031 |
CYP2D6 substrate | 0.444 | CYP2E1 substrate | 0.173 |
CYP3A4 inhibitor | 0.046 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.764 | CL | 7.39 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.004 | Hepatotoxicity | 0.951 |
Mutagenicity | 0.148 | Rat Oral Acute Toxicity | 0.152 |
FDAMDD | 0.068 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.102 | Eye Corrosion | 0.006 |
Eye Irritation | 0.024 | Respiratory Toxicity | 0.002 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.127 | IGC50 | 2.96 |
LC50FM | 3.648 | LC50DM | 4.691 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.129 | NR-AR-LBD | 0.26 |
NR-AhR | 0.005 | NR-Aromatase | 0.074 |
NR-ER | 0.265 | NR-ER-LBD | 0.324 |
NR-PPAR-gamma | 0.464 | SR-ARE | 0.129 |
SR-ATAD5 | 0.342 | SR-HSE | 0.203 |
SR-MMP | 0.02 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.